Hansoh Pharmaceutical Group Company Limited (HKG: 3692)

Hansoh Pharmaceutical Group Company Revenue

Hansoh Pharmaceutical Group Company had revenue of 6.51B CNY in the half year ending June 30, 2024, with 46.71% growth. This brings the company's revenue in the last twelve months to 12.10B, up 27.90% year-over-year. In the year 2023, Hansoh Pharmaceutical Group Company had annual revenue of 10.10B with 7.69% growth.

• Revenue (ttm): 12.10B CNY
• Revenue Growth: +27.90%
• P/S Ratio: 7.85
• Revenue / Employee: 1.33M CNY
• Employees: 9,123
• Market Cap: 102.19B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	10.10B	721.40M	7.69%
Dec 31, 2022	9.38B	-552.73M	-5.56%
Dec 31, 2021	9.94B	1.24B	14.33%
Dec 31, 2020	8.69B	7.49M	0.09%
Dec 31, 2019	8.68B	960.47M	12.44%